Gemmer Asset Management’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-98
Closed -$8K 1500
2019
Q4
$8K Hold
98
﹤0.01% 769
2019
Q3
$5K Hold
98
﹤0.01% 1005
2019
Q2
$4K Hold
98
﹤0.01% 1071
2019
Q1
$3K Sell
98
-17
-15% -$401 ﹤0.01% 1225
2018
Q4
$2K Buy
115
+29
+34% +$675 ﹤0.01% 1268
2018
Q3
$3K Hold
86
﹤0.01% 1240
2018
Q2
$3K Hold
86
﹤0.01% 1252
2018
Q1
$3K Sell
86
-6
-7% -$187 ﹤0.01% 1239
2017
Q4
$3K Buy
92
+19
+26% +$585 ﹤0.01% 1168
2017
Q3
$3K Hold
73
﹤0.01% 1174
2017
Q2
$3K Hold
73
﹤0.01% 1159
2017
Q1
$4K Hold
73
﹤0.01% 1030
2016
Q4
$2K Hold
73
﹤0.01% 1176
2016
Q3
$3K Sell
73
-60
-45% -$2.26K ﹤0.01% 1133
2016
Q2
$4K Buy
133
+60
+82% +$2.12K ﹤0.01% 964
2016
Q1
$2K Sell
73
-79
-52% -$2.58K ﹤0.01% 1144
2015
Q4
$6K Buy
152
+79
+108% +$2.99K ﹤0.01% 802
2015
Q3
$3K Hold
73
﹤0.01% 1030
2015
Q2
$2K Sell
73
-57
-44% -$1.59K ﹤0.01% 1200
2015
Q1
$4K Buy
130
+38
+41% +$1.07K ﹤0.01% 1002
2014
Q4
$3K Sell
92
-44
-32% -$1.09K ﹤0.01% 1087
2014
Q3
$3K Buy
136
+3
+2% +$76 ﹤0.01% 1081
2014
Q2
$4K Buy
133
+17
+15% +$454 ﹤0.01% 1017
2014
Q1
$3K Buy
+116
New +$3.84K ﹤0.01% 1095

Other funds holding MDCO

Gemmer Asset Management's MDCO Position: Q1 2020 in Review

Gemmer Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 98 shares — an estimated $8K sold.

Gemmer Asset Management first reported a position in MDCO in Q1 2014 and held it in 24 quarters. The position peaked at $8K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Gemmer Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Gemmer Asset Management sold 98 Medicines Co shares in Q1 2020, an estimated $8K.
  • Gemmer Asset Management first reported a position in Medicines Co in Q1 2014 and held it in 24 quarters.
  • Gemmer Asset Management's Medicines Co position peaked at $8K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Gemmer Asset Management's 13F filing for Q1 2020, filed 1 May 2020.